Page last updated: 2024-11-06

glutaconic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

glutaconic acid: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

glutaconic acid : A pentenedioic acid that is pent-2-ene substituted by carboxy groups at positions 1 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(E)-glutaconic acid : The (E)-isomer of glutaconic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280498
CHEMBL ID557347
CHEBI ID24309
CHEBI ID15670
SCHEMBL ID12230
MeSH IDM0056906

Synonyms (56)

Synonym
HMS1786D22
AKOS001116898
2-pentenedioic acid
pent-2-enedioic acid
pent-2-ene-1,5-dioic acid
CHEBI:24309
1724-02-3
einecs 217-027-0
CHEBI:15670 ,
(2e)-pent-2-enedioic acid
(e)-glutaconic acid
nsc-227882
nsc227882
glutaconic acid
trans-glutaconate
(e)-glutaconate
trans-glutaconic acid
628-48-8
C02214
trans-glutaconic acid, technical grade, 90%
GLUTACONATE ,
glutaconic acid, >=97.0% (t)
CHEMBL557347
BMSE000435
2e-pentenedioic acid
LMFA01170109
A811411
(e)-pent-2-enedioic acid
unii-noh8k33d47
glutaconic acid, trans
2-pentenedioic acid, (2e)-
noh8k33d47 ,
trans glutaconic acid
G9A ,
SCHEMBL12230
mfcd00002784
(2e)-2-pentenedioic acid
DTXSID70211883
F21361
J-010815
pentenedioic acid
2-pentendioate
1-propene-1,3-dicarboxylic acid
1,3-propenedicarboxylate
1-propene-1,3-dicarboxylate
(e)-2-pentenedioic acid
pentenedioate
1,3-propenedicarboxylic acid
(e)-2-pentenedioate
transglutaconic acid
Q2823263
BS-17351
pent-2-ene-1,5-dioicacid
A868340
glutaconicacid
CS-0145910
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glutaconic acidA pentenedioic acid that is pent-2-ene substituted by carboxy groups at positions 1 and 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Cerebral organic acidurias, including diseases527

Bioassays (6)

Assay IDTitleYearJournalArticle
AID429167Inhibition of wild type human recombinant mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as residual enzyme activity by spectrophotometry in presence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
AID429165Inhibition of human mitochondrial NADP-ME E59L mutant expressed in Escherichia coli XL-1 assessed as residual enzyme activity by spectrophotometry in absence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
AID429166Inhibition of wild type human recombinant mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as residual enzyme activity by spectrophotometry in absence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
AID429164Inhibition of human mitochondrial NADP-ME E59L mutant expressed in Escherichia coli XL-1 assessed as residual enzyme activity by spectrophotometry in presence of fumarate2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (17.65)18.7374
1990's2 (11.76)18.2507
2000's6 (35.29)29.6817
2010's6 (35.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]